Alexandre Becker/LinkedIn
May 15, 2026, 15:46
Alexandre Becker: Clinical Importance of Neonatal Thrombocytopenia in Newborns
Alexandre Becker, Professor of Postgraduate Studies in Clinical Hematology, Hemotherapy, and Quality Management and Control at ULBRA, shared a post on LinkedIn:
”Neonatal Thrombocytopenia
Neonatal thrombocytopenia is a common condition in neonatal intensive care units (15–40percent of infants), serving as a crucial marker of severe diseases such as sepsis, viral infection, necrotizing enterocolitis, or alloimmunization.
Its importance lies in the high risk of bleeding (including intracranial hemorrhage) and the need for rapid diagnosis to differentiate treatable causes and prevent serious sequelae or death.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 26, 2026, 05:12Saja Al-Zamili: Dual Antithrombotic Therapy After Ischemic Stroke in Atrial Fibrillation – A Meta-Analysis
-
Sep 26, 2026, 04:58Angelo Cascio Rizzo: Ischemic Stroke Phenotyping in ESUS – Insights from a Real-World Cohort
-
Sep 26, 2026, 03:11Alice Mihai: One Blood Donation, Three Lives Touched
-
Sep 26, 2026, 03:01Jensa Morris: Anticoagulation in Thrombocytopenia and Cancer-Associated Thrombosis
-
Sep 26, 2026, 02:37Alireza Arzhangzadeh: Antithrombotic Strategies in Coronary Artery Aneurysm, Ectasia, and Slow Flow
-
Sep 26, 2026, 02:15Sherif Mahmoud: Updated Guideline for Antithrombotic-Associated Intracranial Hemorrhage
-
Sep 25, 2026, 20:01Anand Gupta: Timing of DOAC Initiation in Newly Diagnosed Atrial Fibrillation
-
Sep 25, 2026, 19:56Steven Fein: A History of Blood Clots Doesn’t Mean a Healthy Pregnancy Is Out of Reach
-
Sep 25, 2026, 19:54Pedro Perez: “Provoked” VTE May Not Always Mean the Risk Disappears When the Provoking Event Does